Get the Stockscreener App
0.7642
4.91%
-0.0395
Inotiv Inc stock is traded at $0.7642, with a volume of 207.28K.
It is down -4.91% in the last 24 hours and down -31.77% over the past month.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.
See More
Previous Close:
$0.8037
Open:
$0.8
24h Volume:
207.28K
Relative Volume:
0.29
Market Cap:
$26.26M
Revenue:
$505.30M
Net Income/Loss:
$-78.96M
P/E Ratio:
-0.2838
EPS:
-2.6929
Net Cash Flow:
$-46.37M
1W Performance:
-5.39%
1M Performance:
-31.77%
6M Performance:
-67.48%
1Y Performance:
-83.81%
1-Day Range:
$0.7566
$0.8098
1-Week Range:
$0.7566
$0.87
52-Week Range:
$0.657
$6.48
Inotiv Inc Stock (NOTV) Company Profile
Name
Inotiv Inc
Sector
Industry
Phone
(317) 463-4527
Address
2701 KENT AVE, WEST LAFAYETTE
Compare NOTV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NOTV
Inotiv Inc
|
0.7642 | 27.62M | 505.30M | -78.96M | -46.37M | -2.6929 |
|
TMO
Thermo Fisher Scientific Inc
|
572.28 | 217.50B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.33 | 164.13B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
704.20 | 56.49B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
139.68 | 40.44B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
222.26 | 38.48B | 15.90B | 1.28B | 2.21B | 7.2842 |
Inotiv Inc Stock (NOTV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-14-24 | Downgrade | Jefferies | Buy → Hold |
| Feb-09-24 | Upgrade | Jefferies | Hold → Buy |
| Jul-20-23 | Initiated | Wells Fargo | Overweight |
| Jan-19-23 | Downgrade | Jefferies | Buy → Hold |
| Jan-11-23 | Upgrade | Lake Street | Hold → Buy |
| Nov-18-22 | Downgrade | Lake Street | Buy → Hold |
| Oct-04-22 | Initiated | Jefferies | Buy |
| Jan-31-22 | Initiated | Lake Street | Buy |
| Sep-20-21 | Initiated | Craig Hallum | Buy |
View All
Inotiv Inc Stock (NOTV) Latest News
Market Fear: Is Inotiv Inc stock dividend yield sustainable2025 Volume Leaders & Safe Capital Growth Tips - moha.gov.vn
New Highs: Will Alexander Baldwin Inc stock outperform foreign stocksWeekly Risk Report & Fast Gain Swing Alerts - moha.gov.vn
Inotiv partners with Vugene to advance AI-driven drug discovery - TipRanks
Inotiv partners with VUGENE to enhance AI-assisted drug discovery - Investing.com
Inotiv partners with VUGENE to enhance AI-assisted drug discovery By Investing.com - Investing.com Australia
Inotiv, Inc. and VUGENE Announce Strategic Collaboration to Enhance AI-Assisted Drug Discovery and Data Insights - Quiver Quantitative
Inotiv (NASDAQ: NOTV) and VUGENE align on AI drug discovery, bioinformatics push - Stock Titan
Inotiv : Investor Presentation December 2025 - marketscreener.com
Cyber CrimeInotiv Confirms Data Breach Exposing Sensitive Employee Information - teiss
NewsInotiv Confirms Data Breach Exposing Sensitive Employee Information - teiss
Inotiv, Inc. faces business risks amid FDA disruptions and government funding challenges - MSN
Major drug research company confirms cyberattack compromised employee and partner data - Cybersecurity Dive
Full-year loss narrows for Inotiv - Inside INdiana Business
Aug Action: Is Inotiv Inc stock resilient to inflationMarket Trend Report & AI Optimized Trade Strategies - BỘ NỘI VỤ
Inotiv, Inc. reports improved fiscal 2025 results - MSN
Inotiv, Inc. Faces Business Risks Amid FDA Disruptions and Government Funding Challenges - TipRanks
Patterns Watch: Can UWMC stock beat market expectations this quarter2025 Macro Impact & AI Powered Market Entry Ideas - BỘ NỘI VỤ
Inotiv, Inc. Earnings Call: Growth Amid Challenges - TipRanks
CEO Change: Why Inotiv Inc stock is in analyst buy zoneStock Surge & Consistent Growth Stock Picks - moha.gov.vn
Inotiv, Inc. SEC 10-K Report - TradingView — Track All Markets
Inotiv, Inc. (NASDAQ:NOTV) Q4 2025 Earnings Call Transcript - Insider Monkey
Will Inotiv Inc. (BS50) stock outperform foreign stocksQuarterly Earnings Report & Safe Capital Growth Stock Tips - Newser
Is Inotiv Inc. stock a defensive play in 20252025 Top Gainers & Daily Oversold Bounce Ideas - Newser
Will Inotiv Inc. (BS50) stock gain from green policies2025 Volume Leaders & Real-Time Volume Analysis - Newser
Inotiv Inc (NOTV) Q4 2025 Earnings Call Highlights: Revenue Growth Amid Cybersecurity Challenges By GuruFocus - Investing.com Canada
Lake Street Maintains Inotiv (NOTV) Buy Recommendation - Nasdaq
Why Inotiv Inc. stock is a must watch in 2025Quarterly Profit Summary & Real-Time Buy Zone Alerts - Newser
Inotiv (NOTV) Analyst Rating Update: Price Target Lowered by Lak - GuruFocus
Why Inotiv Inc. stock is in analyst buy zone2025 Market Outlook & Daily Profit Maximizing Trade Tips - Newser
How big funds are accumulating Inotiv Inc. (BS50) stockJuly 2025 Spike Watch & Reliable Price Breakout Alerts - Newser
Inotiv, Inc. Reports Improved Fiscal 2025 Results - The Globe and Mail
How forex fluctuations impact Inotiv Inc. (BS50) stockJuly 2025 Review & Entry Point Confirmation Signals - Newser
Inotiv Says Personal Information Stolen in Ransomware Attack - SecurityWeek
Earnings call transcript: Inotiv reports Q4 2025 earnings beat, stock surges By Investing.com - Investing.com India
Earnings call transcript: Inotiv reports Q4 2025 earnings beat, stock surges - Investing.com
Inotiv beats Q4 estimates, but shares flat on debt refinancing concerns By Investing.com - Investing.com South Africa
Inotiv beats Q4 estimates, but shares flat on debt refinancing concerns - Investing.com Canada
Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2025 - TradingView
Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2025 and Provides Business Update - The Manila Times
How Inotiv Inc. (BS50) stock moves on employment dataQuarterly Market Summary & Weekly Chart Analysis and Guides - Newser
Insights Ahead: Inotiv's Quarterly Earnings - Benzinga
Why Inotiv Inc. (BS50) stock could be next leaderMarket Activity Report & Technical Confirmation Trade Alerts - Newser
Can Inotiv Inc. (BS50) stock beat analyst consensusMarket Activity Recap & Entry Point Confirmation Alerts - Newser
How Inotiv Inc. stock reacts to inflationary pressuresWall Street Watch & Expert Verified Stock Movement Alerts - Newser
Why Inotiv Inc. stock could rally in 20252025 Performance Recap & Consistent Growth Equity Picks - BỘ NỘI VỤ
Inotiv Ranked Number 182nd Fastest-Growing Company in North America on the 2025 Deloitte Technology Fast 500 - The Globe and Mail
Inotiv Achieves 182nd Rank on 2025 Deloitte Technology Fast 500 for Revenue Growth of 448% - Quiver Quantitative
Inotiv Ranked Number 182nd Fastest-Growing Company in North America on the 2025 Deloitte Technology Fast 500™ - GlobeNewswire
Inotiv, Inc. to Announce Fiscal 2025 Fourth Quarter and Full Year Financial Results on December 3, 2025 - Quiver Quantitative
Inotiv, Inc. to Report Fiscal 2025 Fourth Quarter and Full - GlobeNewswire
Will Inotiv Inc. stock attract more institutional investorsBull Run & Real-Time Chart Breakout Alerts - newser.com
Inotiv Inc Stock (NOTV) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.15%
0.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):